SOURCE: Rheologics Technologies, Inc.

February 13, 2007 14:46 ET

Market News First's Interview of Rheologics President Now Available Online

EXTON, PA -- (MARKET WIRE) -- February 13, 2007 -- Rheologics Technologies, Inc. (PINKSHEETS: RTGI) ("Rheologics"), the leader in the study of blood viscosity and its relationship to cardiovascular disease, announced that the interview of Daniel Cho, President of Rheologics, by Steve Kanaval on Market News First is now available online.

The interview can be heard by visit the following URL: http://www.mn1.com/members/modules.php?name=Downloads&d_op=getit&lid=725 or by downloading the podcast from Market News First's website at http://www.mn1.com.

During the interview, Mr. Cho answered questions touching on the importance of whole blood viscosity, an overlooked basic biological parameter that Rheologics believes is responsible for the efficiency and health of the cardiovascular system.

About Rheologics Technologies, Inc.

Rheologics is committed to developing and commercializing innovative medical technologies that improve the diagnosis and treatment of human disease. The Company is accomplishing its mission by monitoring an overlooked basic physiological parameter -- whole blood viscosity. Rheologics believes that its innovations will ultimately enable the preventative diagnosis of diseases and the development of new cost-effective therapies that conquer today's most difficult medical problems, thereby improving the quality of life for millions of people worldwide. Further information on Rheologics may be found at www.rheologics.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including but not limited to statements regarding the Company's beliefs and expectations about the performance and benefits of its technology; marketing and commercialization activities; and our beliefs regarding research and development efforts. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ. All forward-looking statements herein are based on information available to us as of the date hereof, and we undertake no obligation to update forward-looking statements to reflect events or circumstances occurring after this date.

Contact Information